220 related articles for article (PubMed ID: 37489919)
21. PET vs sentinel lymph node biopsy for staging melanoma: a patient intervention, comparison, outcome analysis.
El-Maraghi RH; Kielar AZ
J Am Coll Radiol; 2008 Aug; 5(8):924-31. PubMed ID: 18657789
[TBL] [Abstract][Full Text] [Related]
22. Is ultrasound lymph node examination superior to clinical examination in melanoma follow-up? A monocentre cohort study of 373 patients.
Machet L; Nemeth-Normand F; Giraudeau B; Perrinaud A; Tiguemounine J; Ayoub J; Alison D; Vaillant L; Lorette G
Br J Dermatol; 2005 Jan; 152(1):66-70. PubMed ID: 15656802
[TBL] [Abstract][Full Text] [Related]
23. [Follow-up for cutaneous melanoma].
Kettelhack C
Ther Umsch; 2008 Jun; 65(6):335-40. PubMed ID: 18622957
[TBL] [Abstract][Full Text] [Related]
24. Routine PET-CT scans provide early and accurate recurrence detection in asymptomatic stage IIB-III melanoma patients.
Helvind NM; Aros Mardones CA; Hölmich LR; Hendel HW; Bidstrup PE; Sørensen JA; Chakera AH
Eur J Surg Oncol; 2021 Dec; 47(12):3020-3027. PubMed ID: 34120809
[TBL] [Abstract][Full Text] [Related]
25. Staging and follow-up of cutaneous melanoma patients.
Gutiérrez García-Rodrigo C; Antonini A; Rocco T; Pellegrini C; Micantonio T; Fargnoli MC
G Ital Dermatol Venereol; 2017 Jun; 152(3):231-240. PubMed ID: 28195451
[TBL] [Abstract][Full Text] [Related]
26. Findings of computed tomography in stage IIB and IIC melanoma: a six-year retrospective study in the South-East of Scotland.
Orfaniotis G; Mennie JC; Fairbairn N; Butterworth M
J Plast Reconstr Aesthet Surg; 2012 Sep; 65(9):1216-9. PubMed ID: 22525255
[TBL] [Abstract][Full Text] [Related]
27. The Pathogenesis and Clinical Management of Cutaneous Melanoma: An Evidence-Based Review.
Burns D; George J; Aucoin D; Bower J; Burrell S; Gilbert R; Bower N
J Med Imaging Radiat Sci; 2019 Sep; 50(3):460-469.e1. PubMed ID: 31204313
[TBL] [Abstract][Full Text] [Related]
28. The value of lymph node ultrasound and whole body
Stahlie EHA; van der Hiel B; Bruining A; van de Wiel B; Schrage YM; Wouters MWJM; van Houdt WJ; van Akkooi ACJ
Eur J Surg Oncol; 2021 May; 47(5):1157-1162. PubMed ID: 33353826
[TBL] [Abstract][Full Text] [Related]
29. Sentinel lymph node excision and PET-CT in the initial stage of malignant melanoma: a retrospective analysis of 61 patients with malignant melanoma in American Joint Committee on Cancer stages I and II.
Klode J; Dissemond J; Grabbe S; Hillen U; Poeppel T; Boeing C
Dermatol Surg; 2010 Apr; 36(4):439-45. PubMed ID: 20187901
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the American Academy of Dermatology's National Skin Cancer Early Detection and Screening Program.
Koh HK; Norton LA; Geller AC; Sun T; Rigel DS; Miller DR; Sikes RG; Vigeland K; Bachenberg EU; Menon PA; Billon SF; Goldberg G; Scarborough DA; Ramsdell WM; Muscarella VA; Lew RA
J Am Acad Dermatol; 1996 Jun; 34(6):971-8. PubMed ID: 8647990
[TBL] [Abstract][Full Text] [Related]
31. Effectiveness of clinical and instrumental follow-up for cutaneous melanoma.
Toia F; Cajozzo M; Rosatti F; Di Lorenzo S; Rinaldi G; Mazzucco W; Cordova A
Surg Oncol; 2022 Sep; 44():101821. PubMed ID: 35947885
[TBL] [Abstract][Full Text] [Related]
32. Routine restaging PET/CT and detection of initial recurrence in sentinel lymph node positive stage III melanoma.
Baker JJ; Meyers MO; Frank J; Amos KD; Stitzenberg KB; Ollila DW
Am J Surg; 2014 Apr; 207(4):549-54. PubMed ID: 24674829
[TBL] [Abstract][Full Text] [Related]
33. The role of routine imaging in pediatric cutaneous melanoma.
Halalsheh H; Kaste SC; Navid F; Bahrami A; Shulkin BL; Rao B; Kunkel M; Artz N; Pappo A
Pediatr Blood Cancer; 2018 Dec; 65(12):e27412. PubMed ID: 30124237
[TBL] [Abstract][Full Text] [Related]
34. Sentinel lymph node biopsy followed by lymph node dissection for localised primary cutaneous melanoma.
Kyrgidis A; Tzellos T; Mocellin S; Apalla Z; Lallas A; Pilati P; Stratigos A
Cochrane Database Syst Rev; 2015 May; 2015(5):CD010307. PubMed ID: 25978975
[TBL] [Abstract][Full Text] [Related]
35. Methods of melanoma detection and of skin monitoring for individuals at high risk of melanoma: new Australian clinical practice.
Adler NR; Kelly JW; Guitera P; Menzies SW; Chamberlain AJ; Fishburn P; Button-Sloan AE; Heal C; Soyer HP; Thompson JF
Med J Aust; 2019 Jan; 210(1):41-47. PubMed ID: 30636296
[TBL] [Abstract][Full Text] [Related]
36. Clinical practice guidelines for identification, screening and follow-up of individuals at high risk of primary cutaneous melanoma: a systematic review.
Watts CG; Dieng M; Morton RL; Mann GJ; Menzies SW; Cust AE
Br J Dermatol; 2015 Jan; 172(1):33-47. PubMed ID: 25204572
[TBL] [Abstract][Full Text] [Related]
37. The role of positron emission tomography with computed tomography in the follow-up of asymptomatic cutaneous malignant melanoma patients with a high risk of disease recurrence.
Abbott RA; Acland KM; Harries M; O'Doherty M
Melanoma Res; 2011 Oct; 21(5):446-9. PubMed ID: 21849913
[TBL] [Abstract][Full Text] [Related]
38. Teledermatology for diagnosing skin cancer in adults.
Chuchu N; Dinnes J; Takwoingi Y; Matin RN; Bayliss SE; Davenport C; Moreau JF; Bassett O; Godfrey K; O'Sullivan C; Walter FM; Motley R; Deeks JJ; Williams HC;
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD013193. PubMed ID: 30521686
[TBL] [Abstract][Full Text] [Related]
39. Costs of the detection of metastases and follow-up examinations in cutaneous melanoma.
Leiter U; Marghoob AA; Lasithiotakis K; Eigentler TK; Meier F; Meisner C; Garbe C
Melanoma Res; 2009 Feb; 19(1):50-7. PubMed ID: 19430406
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
